Lupin Ltd. rose 0.78 per cent to Rs 1793.1 in Tuesday's trade. It hit an intraday high of Rs 1793.6 and low of Rs 1767.15, respectively, during the day.
The stock quoted a 52-week high price of Rs 1793.6 and low of Rs 896.3.
As of 12:48PM (IST), the counter saw total traded volume of 21,043 shares with a traded value of Rs 3.73 crore, according to NSE.
The stock had closed at Rs 1779.15 in the previous session.
The scrip has advanced 13.18 per cent in the past one month till date, while the benchmark BSE Sensex has gained 10.83 per cent during the same period.
According to exchange data, the stock traded at a price-to-earnings (P/E) multiple of 42.37 while price-to-book ratio stood at 5.16. A higher P/E ratio shows that investors are willing to pay a higher price for per rupee earnings given by the stock because of better future growth expectations. The price-to-book value indicates the inherent value of a company and it reflects the price investors are ready to pay even for no growth in a business.
The stock belongs to the Pharma — Indian industry.
Promoter/FII Holding Promoters held 46.73 per cent stake in the company as of 31-Mar-2024, while FII and MF ownership in the firm stood at 18.28 per cent and 16.82 per cent, respectively.
Key Financials The company reported consolidated sales of Rs 4990.04 crore for the quarter ended 31-Mar-2024, down 4.53 per cent from the previous quarter's Rs 5226.78 crore and down 11.7 per cent from the year-ago quarter's Rs 4467.35 crore. Its net profit for the latest